Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction proced...
Unlocking Q1 Potential of Zimmer (ZBH): Exploring Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Zimmer (ZBH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q...
Why Zimmer (ZBH) is Poised to Beat Earnings Estimates Again
Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in the Cards for Zimmer Biomet (ZBH) in Q1 Earnings?
Within the Hips business, Zimmer Biomet (ZBH) is expected to have witnessed procedure volume recovery, banking on strategic product launches in the first quarter.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why You Should Buy Zimmer Biomet (ZBH) Stock Now
Strategic plans to drive the Knee business bode well for Zimmer Biomet (ZBH).
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zimmer Biomet (ZBH) Q4 Earnings Top Estimates, Margins Grow
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER in the fourth quarter.
Zimmer (ZBH) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Str...
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Surpass Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.20 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $1.88 per share a year ago.
Zimmer Biomet forecasts upbeat 2024 profit on steady medical devices demand
Zimmer Biomet Holdings Inc forecast 2024 profit above Wall Street expectations on Thursday, betting on resilient demand for its medical devices, and said it had initiated a restructuring program la...
Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
What's in Store for Zimmer Biomet (ZBH) in Q4 Earnings?
Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter.
Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Zimmer Biomet is focusing on growth acceleration after spinning off divisions and refocusing on high-growth areas in the medical device market. The company's growth target is supported by investmen...
3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your Portfolio
Zimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock.
Related Companies